Patents
Literature
3 results about "Metoprolol" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Metoprolol, marketed under the tradename Lopressor among others, is a medication of the selective β₁ receptor blocker type. It is used to treat high blood pressure, chest pain due to poor blood flow to the heart, and a number of conditions involving an abnormally fast heart rate. It is also used to prevent further heart problems after myocardial infarction and to prevent headaches in those with migraines.
Method for modulating neuropathies
Abstract The present invention relates to a method for modulating neuropathies. The method comprises: administering to a subject a therapeutically effective amount of doxazosin, a pharmaceutically acceptable salt or an acceptable form thereof, a therapeutically effective amount of pramipexole, a pharmaceutically acceptable salt or an acceptable form thereof, and a 5 therapeutically effective amount of metoprolol, a pharmaceutically acceptable salt or an acceptable form thereof. Abstract 20 26 20 52 65 03 J ul 2 02 6 A b s t r a c t 2 0 2 6 2 0 5 2 6 5 0 3 J u l 2 0 2 6
Owner:CHENGDU WENDING TECH DEV CO LTD
Polymorphs of metoprolol and its salts
This invention relates to polymorphs of metoprolol and its salts. Crystal forms and combinations thereof of the free base of metoprolol selected from polymorphs A, B, C, D, E, F, and G are disclosed, as well as crystalline polymorphs of salts of metoprolol. Pharmaceutical compositions containing one or more of these polymorphs and methods for preparing such polymorphs are also disclosed. Metoprolol can be used to treat a variety of diseases associated with low intracellular BH4 levels, such as phenylketonuria.
Owner:PTC THERAPEUTICS MP INC
Compositions and methods for treating graft-related arrhythmia
PendingUS20260097012A1Unknown materialsNitrile/isonitrile active ingredientsCardiac arrhythmiaIvabradine
Provided herein are methods of treating or preventing an arrhythmia in a cardiac graft patient, wherein the method comprises administering combinations of anti-arrhythmic agents (e.g., amiodarone, metoprolol, ivabradine, and / or mexiletine) to the subject in need thereof.
Owner:BLUEROCK THERAPEUTICS LP